U.S. market Closed. Opens in 12 hours 2 minutes

RSLS | ReShape Lifesciences Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-31
Revenue8.68M11.24M13.60M11.30M15.09M606.71K1.29M786.66K292.00KN/AN/A311.49KN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue3.13M4.44M5.25M5.04M5.78M164.30K936.39K431.48K125.05KN/AN/A231.52KN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit5.55M6.80M8.35M6.26M9.30M442.41K350.77K355.18K166.95KN/AN/A79.97KN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Expenses20.19M33.88M36.10M18.72M25.19M24.98M31.76M23.15M28.03M25.59M24.73M22.63M25.26M16.18M24.21M36.27MN/AN/AN/AN/AN/A
Selling, General & Admin17.87M31.34M33.58M15.22M22.07M19.26M25.98M17.98M19.89M14.56M13.66M11.96M8.58M7.68M8.63M8.60M6.97M3.76M2.32MN/AN/A
Research & Development2.31M2.54M2.52M3.50M3.12M5.72M5.78M5.17M8.14M11.03M11.08M10.67M16.67M8.50M15.58M27.67M21.05M14.36M8.83MN/AN/A
Other Operating Expenses122.00K11.00K23.50M306.00K-1.34M-10.64KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-14.64M-27.08M-27.75M-12.46M-15.89M-38.55M-31.41M-22.80M-27.87M-25.59M-24.73M-22.55M-25.26M-16.18M-24.21M-36.27M-28.03M-18.12M-11.15MN/AN/A
Other Expenses / Income3.30M-19.52M-34.29M-9.35M-59.21M-14.16M-4.72M-565.22K2.37M-535.45K-1.05M-911.14K-30.12K82.54K-35.62M-21.86K-456.88K5.59K8.36KN/AN/A
Before Tax Income-11.34M-46.59M-62.04M-21.81M-75.10M-38.71M-36.13M-23.36M-25.50M-26.13M-25.78M-23.46MN/AN/AN/AN/AN/AN/AN/AN/AN/A
Income Tax Expenses52.00K-380.00K-106.00K-181.00K-893.00K-3.45M-2.31MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-11.39M-46.21M-61.93M-21.63M-74.21M-81.15M-33.82M-23.36M-25.50M-26.13M-25.78M-23.46M-26.00M-17.35M-31.93M-37.87M-28.58M-17.69M-11.22M-3.45M-1.90M
Interest Expenses-26.00K113.00K832.00K2.05M451.00K12.38K3.87K4.10M939.18K530.22K932.36K901.84K722.86K1.26M4.10M2.68M1.65M710.11K181.15KN/AN/A
Basic Shares Outstanding5.96M424.39K218.52K26.03K31.38KN/A220.44K622.43K17.78M17.78M17.78M17.78M17.78M17.78M17.78M17.78M17.78M17.78M17.78M17.78M17.78M
Diluted Shares Outstanding5.96M424.39K218.52K26.03K31.38KN/A220.44K622.43K17.78M17.78M17.78M17.78M17.78M17.78M17.78M17.78M17.78M17.78M17.78M17.78M17.78M
EBITDA-14.48M-24.91M-27.75M-12.46M-17.22M-24.11M-35.20M-19.12M-24.37M-25.40M-24.56M-22.33M-24.95M-15.80M-23.79M-35.76M-26.58M-18.03M-11.02MN/AN/A
EBITDA Margin-166.92%-221.65%-204.04%-110.25%-114.15%-3,974.13%-2,734.97%-2,430.18%-8,346.22%0.00%0.00%-7,169.11%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-11.36M-46.48M-61.21M-19.76M-74.65M-84.59M-36.13M-19.26M-24.56M-25.60M-24.85M-22.56M-25.27M-16.09M-27.82M-35.19M-26.93M-16.98M-11.03M-3.45M-1.90M
EBIT Margin-130.92%-413.53%-450.05%-174.90%-494.72%-13,941.74%-2,806.87%-2,447.92%-8,410.81%0.00%0.00%-7,241.98%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙